165 related articles for article (PubMed ID: 30565866)
1. Relationship Between Patterns in Antihypertensive Drugs Medication and Mortality in Incident Dialysis Patients: A Multicenter Prospective Cohort Study.
Fujii M; Inaguma D; Koide S; Ito E; Takahashi K; Hayashi H; Tsuboi N; Hasegawa M; Yuzawa Y
Ther Apher Dial; 2019 Aug; 23(4):353-361. PubMed ID: 30565866
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis.
Chang TI; Zheng Y; Montez-Rath ME; Winkelmayer WC
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1401-1412. PubMed ID: 27354656
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
5. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
[TBL] [Abstract][Full Text] [Related]
6. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
Okano GJ; Rascati KL; Wilson JP; Remund DD; Grabenstein JD; Brixner DI
Clin Ther; 1997; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
[TBL] [Abstract][Full Text] [Related]
7. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
[TBL] [Abstract][Full Text] [Related]
8. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.
Shafi T; Sozio SM; Luly J; Bandeen-Roche KJ; St Peter WL; Ephraim PL; McDermott A; Herzog CA; Crews DC; Scialla JJ; Tangri N; Miskulin DC; Michels WM; Jaar BG; Zager PG; Meyer KB; Wu AW; Boulware LE;
Medicine (Baltimore); 2017 Feb; 96(5):e5924. PubMed ID: 28151871
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Characteristics and Antihypertensive Medications for Mortality of Elderly Hospitalized Hemodialysis patients: a Multicenter Retrospective Study in China.
Song YH; Cai GY; Xiao YF; Liu JQ; Chen XM
Saudi J Kidney Dis Transpl; 2021; 32(3):637-644. PubMed ID: 35102905
[TBL] [Abstract][Full Text] [Related]
11. Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study.
Lee CJ; Hwang J; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
J Hypertens; 2017 May; 35 Suppl 1():S41-S49. PubMed ID: 28350620
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Medication Selection Model Under Clinical Application of Renin-Angiotensin Inhibitor Combined with Calcium Channel Blocker for Hypertension Patients.
Hong D; Shi W; Lu X; Lou Y; Li L
Med Sci Monit; 2020 Apr; 26():e923696. PubMed ID: 32285846
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.
Ishida T; Oh A; Hiroi S; Shimasaki Y; Nishigaki N; Tsuchihashi T
Hypertens Res; 2019 Feb; 42(2):249-256. PubMed ID: 30443023
[TBL] [Abstract][Full Text] [Related]
15. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
16. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
17. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of antihypertensive drugs in hypertensive patients with end stage renal failure.
Kumolosasi E; Ng WB; Abdul Aziz SA
Med J Malaysia; 2012 Aug; 67(4):379-85. PubMed ID: 23082445
[TBL] [Abstract][Full Text] [Related]
19. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
